Search Results - "Haciefendi, Ayten"
-
1
Mechanisms of abemaciclib, a CDK4/6 inhibitor, induced apoptotic cell death in prostate cancer cells in vitro
Published in Translational oncology (01-01-2022)“…•ABE treatment may be a promising treatment strategy in especially mCRPC.•ABE treatment significantly inhibited PC cell growth through apoptosis,…”
Get full text
Journal Article -
2
Novel combination treatment of CDK 4/6 inhibitors with PARP inhibitors in triple negative breast cancer cells
Published in Naunyn-Schmiedeberg's archives of pharmacology (01-05-2023)“…Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors provide promising results for treating hormone receptor-positive breast cancer. However, the efficacy of CDK4/6…”
Get full text
Journal Article -
3
The suppression of ATR/Chk1 pathway by Elimusertib ATR inhibitor in triple negative breast cancer cells
Published in American journal of translational research (01-01-2023)“…Genomic instability in cancer cells is based on the aberrant activation of deoxyribonucleic acid (DNA) damage response and repair mechanisms. Targeting Ataxia…”
Get full text
Journal Article -
4
The ATR inhibition by Elimusertib enhances the radiosensitivity of MDA-MB-231 triple negative breast cancer in vitro
Published in International journal of radiation biology (03-05-2024)“…DNA damage response (DDR) is the principal mechanism regulating genomic stability and cell cycle checkpoint activation by coordinating DNA repair and apoptotic…”
Get full text
Journal Article -
5
The prognostic and predictive values of differential expression of exosomal receptor tyrosine kinases and associated with the PI3K/AKT/mTOR signaling in breast cancer patients undergoing neoadjuvant chemotherapy
Published in Clinical & translational oncology (01-02-2023)“…Purpose Cancer cell-derived exosomes are the mediator of the tumor microenvironment and the molecular content of exosomes presents a promising prognostic or…”
Get full text
Journal Article